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Abstract We report a 44-year-old woman who developed
a fatal pulmonary embolus after uterine artery ﬁbroid em-
bolisation (UAE). Bilateral UAE was carried out through a
single right-femoral artery puncture. The largest ﬁbroid in
the anterior fundal wall measured 4.5 cm, and the largest
ﬁbroid in the posterior fundal wall measured 6 cm. The
appearances after UAE were satisfactory, and the proce-
dure was apparently uneventful. No immediate complica-
tions were noted. The patient developed sudden-onset
shortness of breath and went into cardiac arrest 19 h after
the procedure. Postmortem autopsy conﬁrmed that the
cause of a death was a pulmonary embolism. To our
knowledge this is the ﬁrst reported case in the United
Kingdom in which death occurred from a pulmonary
embolus after UAE.
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Introduction
Uterine artery ﬁbroid embolisation (UAE) has now been
used in clinical practice for[2 decades in the management
of symptomatic uterine ﬁbroids [1, 2]. It is estimated that
[50,000 procedures have been performed worldwide since
Ravina reported his series in France in 1995 [3, 4].
UAE is emerging as an effective alternative to hyster-
ectomy and myomectomy in women with ﬁbroids.
Although long-term follow up data are still lacking, early
reports regarding its safety and efﬁcacy have been
encouraging, and the procedure is increasingly being
accepted [1]. However, there is a lack of evidence on future
fertility and pregnancy outcomes in women undergoing
UAE [5]. We report here a case of death from a pulmonary
embolus after UAE.
Case Report
A 44-year-old nulliparous woman with a body mass index
of 27 underwent UAE in July 2008 for symptomatic relief
of heavy menstrual bleeding. She had previously under-
gone endoscopic resection of a submucous ﬁbroid in 2002
and open myomectomy in 2003. She subsequently under-
went exploratory laparotomy and division of adhesions for
relief of small-bowel obstruction in February 2007. A
subsequent hysteroscopy in November 2007 showed a
large cavity distorted by ﬁbroids. A pelvic ultrasound scan
before her procedure showed an antiverted, enlarged uterus
measuring approximately 13.5 9 8 9 9 cm. The myome-
trium was noted to be diffusely heterogenous, containing
multiple ﬁbroids in the anterior and posterior walls. The
largest ﬁbroid measured 6 cm. Bilateral UAE was carried
out through a single right–femoral artery puncture using a
5F sheath, a 4F catheter, and a 3F coaxial catheter. Mul-
tiple injections of contrast were administered into the
internal iliac arteries and uterine arteries. The uterus was
noted to be hypervascular and supplied by hypertrophied
uterine arteries. Each uterine artery was selectively cathe-
terised and embolised with polyvinyl alcohol particles
(William Cook Europe, Bjaeverskov, Denmark). One vial
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particles 510–700 lm in diameter were used. The end point
of the embolisation process was near-stasis in the uterine
artery. The appearances after UAE were satisfactory. The
procedure lasted approximately 40 min and was apparently
uneventful. No immediate complications were noted.
The patient was admitted for observation overnight. The
plan was for her to be on bed rest for 12 h for observation
of the puncture site for bleeding or swelling and adminis-
tration of analgesia (diclofenac sodium and paracetamol).
Nineteen hours after the procedure, the patient had
sudden-onset shortness of breath and collapsed. She was
noted to be semicomatose with a Glasgow Coma Scale
score of eight. She then had respiratory arrest, followed by
cardiac arrest. She received cardiopulmonary resuscitation
(CPR) for [1 h. However, there was no cardiac activity
throughout CPR, and she was noted to have pulseless
electrical activity on cardiac monitoring. CPR was dis-
continued after 1 h and 10 min, and the patient was pro-
nounced dead. Postmortem autopsy conﬁrmed that the
cause of a death was pulmonary embolism.
Discussion
To our knowledge this is the ﬁrst reported case in the
United Kingdom in which death occurred from pulmonary
embolisation after UAE. The embolisation procedure had
appeared routine. The embolic agents used and the quantity
thereof were not unusual. The size of the uterus was not
considered likely to have caused compression and stasis in
the lower-limb venous structures. Certainly, patients with
symptoms from a uterus of greater size than that seen in
this patient have been treated at our institution. It is not
clear from the postmortem autopsy if the origin of the
embolus was from the pelvic or the lower-limb veins.
Theoretically, it is possible to surmise that pelvic veins are
enlarged and engorged in the presence of multiple hyper
vascular ﬁbroids, which consequently have decreased ﬂow
after embolisation, thus producing a potential scenario for
thrombosis. Relative contrast stasis can be visualised in
veins draining the uterus during any embolisation proce-
dure. The patient was kept for overnight observation per
hospital policy. If the treatment had been carried out as a
day case, then death would have occurred at home. The
precipitous nature of the events raises the question as to
whether there was a pre-existing thrombosis, which may
have rapidly progressed after UAE. There was a history of
previous pelvic surgery; however, there was no clinical
evidence for pelvic or lower-limb venous thrombosis or
clinical history of thrombotic tendency before the embol-
isation procedure was performed.
At least ﬁve deaths have been reported after UAE. Two
women died after UAE from septic shock, one in the
United Kingdom [6] and the other in The Netherlands [7].
One woman with known breast cancer died in Italy several
days after UAE from a pulmonary embolus [8], and two
women died in the United States from pulmonary emboli
after the procedure [5].
Although the risk of developing a fatal venous throm-
boembolus is considered low, there have so far been at
least four reported cases in the literature. We advocate that
women undergoing this procedure should routinely receive
thromboprophylaxis in the form of thromboembolic-
deterrent stockings. However, these would be of no beneﬁt
from an embolus originating in the pelvic veins. Further
research is needed to assess the role of thromboprophylaxis
using heparin-like agents with this procedure. At present,
there is no evidence that their use would be of beneﬁt.
Indeed, the use of such agents to decrease the incidence of
embolic events (which are already rare relative to the
number of procedures performed) may be accompanied by
increased bleeding complications or more ineffective em-
bolisation procedures (and therefore poor clinical out-
comes) that rely on inducing local vessel thrombosis as
well as physical occlusion. It is not possible to say if
patients with a previous history of pelvic surgery are at
greater risk of embolus after UAE.
The continued reporting of all UAE cases to a National
Registry would allow us to monitor the number of women
undergoing the procedure, the number and type of com-
plications, and the fertility outcomes in all such cases.
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